Switch View
© ACCESSWIRE
03.09.2025
ISIN: GB00BYX3WZ24
Hemogenyx Pharmaceuticals plc
HEMO
LISTED
LSE
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
News Preview
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN. LON...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.09.2025
ISIN: US18978H5081
CNS Pharmaceuticals Inc
CNSP
LISTED
NASDAQ
CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
HOUSTON, TX / ACCESS Newswire / September 3, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that it will present at the H.C. Wainwri...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Sept. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Replimune Group, Inc. ("Replimune" or "the Company") (NASDAQ: REPL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by t...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
03.09.2025
ISIN: JP3546800008
Terumo Corporation
45430
LISTED
XJPX
Terumo Neuro Launches Aneurysm Treatment Alliance in EMEA to Advance Physician Collaboration and Aneurysm Care
News Preview
"Bringing Effective Solutions to Life" Through A Dedicated EMEA Initiative Designed to Simplify Collaboration, Showcase A Comprehensive Hemorrhagic Portfolio, And Empower Physicians to Improve Patient Outcomes
MARSEILLE, France, Sept. 3, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary o...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
03.09.2025
ISIN: JP3546800008
Terumo Corporation
45430
LISTED
XJPX
Terumo Neuro Unveils New SOFIA™ Flow 88 Neurovascular Aspiration Catheter Data from EMEA Demonstrating Strong Performance
News Preview
Real-World EMEA Physician Preference Data1 Demonstrates the SOFIA Flow 88 Aspiration Catheter's Trackability, Navigation, and Overall Performance in Stroke Procedures
MARSEILLE, France, Sept. 3, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today unveiled new re...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.09.2025
ISIN: US14757U2087
CASI Pharmaceuticals, Inc.
CASI
LISTED
NASDAQ
CASI Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference
News Preview
SOUTH SAN FRANCISCO, CA / ACCESS Newswire / September 3, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with organ transplant rejection and autoimmune diseases, today announced that David Cory, CEO, will present a company update at the H.C. Wainwrig...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.09.2025
ISIN: US7389201077
Aspire Biopharma Holdings, Inc
ASBP
LISTED
NASDAQ
Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
News Preview
Aspire's sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes after dosingTxB2 is a biomarker indicating aspirin's effect on platelet aggregation, the clumping of platelets that leads to dangerous blood clotsThis rapid inhibition is critical during suspected heart attacks, when clots blocki...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.09.2025
ISIN: US12482V1035
CBD Life Sciences Inc.
CBDL
LISTED
OTC
CBD Life Sciences Inc. (CBDL) Announces President Trump Confirms Marijuana Rescheduling Is Under Consideration
News Preview
"A shift to Schedule III could unlock a $30+ billion market, eliminate crippling 280E tax burdens, unleash institutional investment, and set the stage for explosive industry-wide growth." SCOTTSDALE, ARIZONA / ACCESS Newswire / September 3, 2025 / CBD Life Sciences Inc. (OTC:CBDL), a leader in the development and sale of high-quality CBD...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.09.2025
ISIN: CA98980M1095
Zomedica Corporation
ZOM
LISTED
XASE
Zomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation Portfolio
News Preview
Strategic partnership with Pioneer Veterinary Products Limited expands Zomedica's presence in the UK veterinary market through distribution of its leading point-of-care solutions ANN ARBOR, MI / ACCESS Newswire / September 3, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
Rolling sBLA initiated to the U.S. FDA for Leqembi® Iqlik™ (lecanemab-irmb) as a subcutaneous starting dose for the treatment of early Alzheimer's disease under Fast Track status
News Preview
STOCKHOLM, Sept. 3, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that they have initiated a rolling submission of the Supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Leqembi Iqlik (lecanemab-irmb) subcutaneous autoinjector, as a weekly star...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
Rolling sBLA initiated to the U.S. FDA for Leqembi® Iqlik™ (lecanemab-irmb) as a subcutaneous starting dose for the treatment of early Alzheimer's disease under Fast Track status
News Preview
STOCKHOLM, Sept. 2, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that they have initiated a rolling submission of the Supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Leqembi Iqlik (lecanemab-irmb) subcutaneous autoinjector, as a weekly star...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Sept. 2, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclus...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
03.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the "Class Period"), of the important September 22, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US09073N2018
BioSig Technologies, Inc.
BSGM
LISTED
NASDAQ
BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected
News Preview
Proposal No. 1 (The Acquisition Proposal) to be adjourned pending final NASDAQ approval; Company operations, financings and closing of the merger transaction remain not impacted Proposal No. 1 (The Acquisition Proposal) to be adjourned pending final NASDAQ approval; Company operations, financings and closing of the merger transaction remain not imp...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
ANRO STOCK NEWS: Alto Neuroscience, Inc. Investors are Reminded of the Pending Lead Plaintiff Deadline; Contact Robbins LLP for Information on Leading the Class Action
News Preview
SAN DIEGO, Sept. 2, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired (a) Alto Neuroscience, Inc. (NYSE: ANRO) common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company's initial public offering ("IPO") conduct...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: US6031701013
Mineralys Therapeutics Inc
MLYS
LISTED
NASDAQ
Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock
News Preview
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announce...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2025
ISIN: JP3160400002
Eisai Co Ltd
45230
LISTED
XJPX
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
News Preview
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from the start to help patients and care partners treat this progressive, relentless disease
TOKYO and CAMBRIDGE, Mass., Sept. 2, 2025 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
ISIN: GB00BMVP7Y09
Royalty Pharma PLC
RPRX
LISTED
NASDAQ
Royalty Pharma Announces Pricing of $2.0 Billion of Senior Unsecured Notes
News Preview
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today that it has priced an offering of $2.0 billion of senior unsecured notes, comprised of the following (collectively, the “Notes”):...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
STAAR Surgical Reiterates Compelling, Premium Cash Value Provided by Alcon Merger
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, issued the following statement:
“The merger with Alcon provides STAAR stockholders with compelling, premium cash value, including a 51% premium to the closing price of STAAR common stock on...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
NEOG DEADLINE: NEOG Investors with Losses in Excess of $100K Have Opportunity to Lead Neogen Corporation Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025 (the "Class Period"), of the important September 16, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status
News Preview
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from the start to help patients and care partners treat this progressive, relentless disease LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection f...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
SHAREHOLDER ALERT: Berger Montague Reminds Altimmune, Inc. (NASDAQ: ALT) Investors of Class Action Lawsuit Deadline
News Preview
PHILADELPHIA, Sept. 2, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Altimmune Inc. (NASDAQ: ALT) ("Altimmune" or the "Company") on behalf of investors who purchased or otherwise acquired publicly traded securities of Altimmune between August 10, 2023 through June 25, 2025 (the "Cla...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
AGILON HEALTH INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of agilon health, inc. - AGL
News Preview
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has continued its investigation into agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL).
On January 5, 2024, the Company disclosed that it was slashing its 2023 profit forecasts, specifica...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US2358511028
Danaher Corp
DHR
LISTED
NYSE
DANAHER INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Danaher Corporation - DHR
News Preview
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Danaher Corporation (NYSE: DHR).
On April 25, 2023, the Company disclosed that "[r]evenues decreased 7.0% year-over-year to $7.2 billion, with a 4.0% non-GAAP co...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US30161Q1040
Exelixis Inc
EXEL
LISTED
NASDAQ
EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Exelixis, Inc. (“Exelixis” or “the Company”) (NASDAQ: EXEL) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disc...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US6556631025
Nordson Corp
NDSN
LISTED
NASDAQ
Nordson MEDICAL Completes Divestiture of Select Contract Manufacturing Products, Narrowing its Focus on Proprietary Medical Components
News Preview
Nordson Corporation (Nasdaq: NDSN) has completed the divestiture of select product lines within its medical contract manufacturing business to Quasar Medical.
“This divestiture allows Nordson MEDICAL to focus on its higher value growth opportunities within our $800 million medical and fluid solutions segment. This includes our growing portfolio...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Law Offices of Howard G. Smith Encourages Semler Scientific Inc. (SMLR) Investors To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025, inclusive (the “Class Period”). Semler investors have until October 28, 2025 to file a lead plaintiff motion...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: GG00BMF1JR16
Genius Sports Limited
GENI
LISTED
NYSE
Genius Sports to Host Investor Day on Wednesday, December 3, 2025
News Preview
Genius Sports Limited (NYSE:GENI) (“Genius Sports” or the “Company”), the official data, technology and broadcast partner that powers the global ecosystem connecting sports, betting and media, today announced that it will host an Investor Day in New York City on Wednesday, December 3, 2025.
The event will feature presentations from Genius Sports...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US81619Q1058
Select Medical Holdings Corp
SEM
LISTED
NYSE
SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS
News Preview
MECHANICSBURG, Pa., Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) today announced the appointment of Thomas P. Mullin as its chief executive officer. David S. Chernow, who has held the position since 2014, has been appointed vice chairman of the board. John A. Saich, who most recently held the...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US74587V1070
Puma Biotechnology Inc
PBYI
LISTED
NASDAQ
Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 1:00 p.m. EDT on Monday, September 8, at the H.C. Wainwright 27th Annual Global Investment Conference. The conference will be held Septem...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US48576U2050
Karyopharm Therapeutics Inc
KPTI
LISTED
NASDAQ
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
NEWTON, Mass., Sept. 2, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 466 restricted stock units (RSUs) to two newly-hired employees. These RSU awards were granted as of August 31, 2025 (the "Gr...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: CH0499880968
ADC Therapeutics SA
ADCT
LISTED
NYSE
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
News Preview
LAUSANNE, Switzerland, Sept. 2, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of 29,700 of the Company's common shares to two new employees on September 2, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US22053A1079
Quince Therapeutics Inc
CRTX
LISTED
NASDAQ
Quince Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that Dirk Thye, M.D., Quince’s Chief Executive Officer and Chief Medical Officer, will participate at the H.C. Wainwright 27th Annual Global Investment Conferen...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US03969F1093
Arcus Biosciences Inc
RCUS
LISTED
NYSE
Arcus Biosciences to Host Investor Event to Highlight its Late-Stage Casdatifan Program and Next Wave of Programs Focused on Inflammation
News Preview
Arcus Biosciences (NYSE:RCUS) announced today that it will host an in-person and virtual Investor Event for analysts and investors on Monday, October 6, 2025, beginning at 10:00 AM ET, in New York City.
The event will highlight new data for Arcus’s HIF-2a inhibitor casdatifan from the monotherapy cohorts of the Phase 1b ARC-20 trial in late-line...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US62857J2015
Myomo, Inc.
MYO
LISTED
XASE
Myomo to Present at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer, and David Henry, chief financial officer, will present at the H.C. W...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US48301N1046
Kairos Pharma Ltd
KAPA
LISTED
XASE
Kairos Pharma to Present at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces that John Yu, MD, CEO and Chairman, will present a corporate overview at the H.C. Wainwright 27th Annual Global Investment Conference. The conference is being held on September 8 – 10, 2025 at the Lotte N...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US71944F1066
Phreesia, Inc.
PHR
LISTED
NYSE
Phreesia Launches VoiceAI, a Conversational AI Solution to Transform Call Management in Healthcare
News Preview
Phreesia, a leader in patient activation, today announced the launch of Phreesia VoiceAI, an always-on, intelligent AI phone solution purpose-built for healthcare. VoiceAI leverages advanced natural language processing and real-time workflow integration to help healthcare organizations manage high call volumes, streamline routine interactions and...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US4928541048
Kewaunee Scientific Corporation
KEQU
LISTED
NASDAQ
Kewaunee Scientific to Attend the 2025 Arablab Live Trade Show in Dubai
News Preview
STATESVILLE, N.C., Sept. 2, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company will attend the 2025 Arablab Live tradeshow and conference, taking place in Dubai from September 23-25....
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US14167L1035
CareDx Inc
CDNA
LISTED
NASDAQ
CareDx Issues Comment Letter on Draft LCD Policy
News Preview
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it has submitted its comment letter in response to the draft Local Cove...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US1167941087
Bruker Corp
BRKR
LISTED
NASDAQ
Bruker Announces Public Offering of $600 Million of Mandatory Convertible Preferred Stock
News Preview
Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced it has commenced a public offering, subject to market and other conditions, of $600.0 million of Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock”). Bruker expects to grant the underwriters a 30-day option to purchase...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US71742Q1067
Phibro Animal Health Corp
PAHC
LISTED
NASDAQ
Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference
News Preview
Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference.
Chief Financial Officer, Glenn David will address financial analysts and investors on Tuesday, September 9, 2025, at 12:20 PM ET at the Sheraton New York Times Square Hotel.
The live audio presentation...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Ionis to present at upcoming investor conferences
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:
2025 Wells Fargo Healthcare Conference on Thursday, September 4, 2025
H.C. Wainwright 27th Annual Global Investment Conference on Monday, September 8, 2025
Morgan Stanley 23rd Annual Global H...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: JP3160400002
Eisai Co Ltd
45230
LISTED
XJPX
FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
News Preview
A link has been updated in this news release, FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease, issued 29-Aug-2025 by Eisai Inc. over PR Newswire.
FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US98943L1070
Zentalis Pharmaceuticals Inc
ZNTL
LISTED
NASDAQ
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types, today announced that on September 2, 2025, the Compensation Committee of Zentalis’...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: GB00BMX86B70
Haleon PLC
HLN
LISTED
LSE
TUMS helps Second Harvest tackle hunger in Canada for the fourth year in a row
News Preview
TORONTO, Sept. 2, 2025 /CNW/ - Food waste is an avoidable problem, yet at least 10 million people continue to face food insecurity in Canada. In July 2025, StatsCan reported that the employment rate continued to drop, while also noting that there has been little net employment growth since the beginning of the year1. With numbers like this, it's...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US75340L1044
Rapid Micro Biosystems Inc
RPID
LISTED
NASDAQ
Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
LEXINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at t...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US5560991094
MacroGenics Inc
MGNX
LISTED
NASDAQ
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
News Preview
ROCKVILLE, MD, Sept. 02, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that MacroGenics’ President & Chief Executive Officer, Eric Risser, will present at the H.C. Wainwright 27th Annual Global Inv...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: IL0006290147
Teva Pharmaceutical Industries Ltd
TEVA
LISTED
TLV
Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September
News Preview
TEL AVIV, Israel, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in September as follows:...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US29384C1080
Entrada Therapeutics Inc
TRDA
LISTED
NASDAQ
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 54,360 restricted stock units (“RSUs”) and options to purchase 38,850 shares of the Company’s common stock to seven newly-hired non-executive employees under the Company’s 2025 Inducement Equity Plan (the “...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US79957L1008
Sanara Medtech Inc
SMTI
LISTED
NASDAQ
Sanara MedTech Inc. Announces Chief Executive Officer Transition
News Preview
Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah Announces Upcoming Investor Events
News Preview
Nyxoah Announces Upcoming Investor Events...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US5009461089
Korro Bio Inc
KRRO
LISTED
NASDAQ
Korro to Participate in Upcoming Investor and Scientific Conferences
News Preview
CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences for the month of September:...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US92243A2006
Vaxart Inc
VXRT
LISTED
NASDAQ
Vaxart Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors
News Preview
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that its Chairman, Michael J. Finney, Ph.D., has announced his retirement fr...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva to Present at Upcoming Investor Conference
News Preview
PLEASANTON, Calif., Sept. 2, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conferences:
Citi's 2025 Global TMT Conference, New York, NY. Brian Van Wagener, CFO, and Paul Shawah, EVP Strategy, will present on Thursday, September 4, 2025, at 2:10 p.m. Eastern Time.The above presentations wi...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US87990A1060
Tenaya Therapeutics Inc
TNYA
LISTED
NASDAQ
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Tenaya’s Chief Executive Officer, will...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US00972D1054
Akebia Therapeutics Inc
AKBA
LISTED
NASDAQ
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted two newly-hired employees options to purchase an aggregate of 95,100 shares of Akebia’s common stock on August 29, 2025. The options were gra...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US01626L1052
Aligos Therapeutics, Inc.
ALGS
LISTED
NASDAQ
Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that members of management will present at the H.C. Wainwright 27th Annual Global In...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US82657M1053
Sight Sciences Inc
SGHT
LISTED
NASDAQ
Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO
News Preview
This report provides an evidence-based review of current treatments for managing dry eye disease (DED) and highlights support for TearCare based on strong clinical data This report provides an evidence-based review of current treatments for managing dry eye disease (DED) and highlights support for TearCare based on strong clinical data...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US04300J1079
Protara Therapeutics, Inc.
TARA
LISTED
NASDAQ
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recent grants of inducement non-qualified stock options and restricted stock units (RSUs) to two newly-...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US5147661046
Lifecore Biomedical Inc
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Participate in Upcoming Investor Conferences
News Preview
CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple upcoming investor conferences. Details regarding Lifecore’s participation are as follows:...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
